Viveve Medical (VIVE) Misses Q3 EPS by 8c, Beats on Revenues

Viveve Medical (NASDAQ: VIVE) reported Q3 EPS of ($0.50), $0.08 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $3.71 million.

For earnings history and earnings-related data on Viveve Medical (VIVE) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Carnival shares drop despite earnings beat on weak guidance
• Creatd files Form S-1 and reports Q1 2026 financial results